Trials / Conditions / Myelodysplastic Syndrome (MDS)/AML
Myelodysplastic Syndrome (MDS)/AML
3 registered clinical trials studyying Myelodysplastic Syndrome (MDS)/AML — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS NCT07347418 | University of Colorado, Denver | Phase 1 |
| Recruiting | Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS NCT07532824 | Institute of Hematology and Blood Transfusion, Czech Republic | Phase 1 / Phase 2 |
| Terminated | A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS NCT06563804 | Servier Bio-Innovation LLC | Phase 1 / Phase 2 |